Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-24-005256
Filing Date
2024-11-14
Accepted
2024-11-14 16:32:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 alyeska-kprx093024.htm SC 13G 104773
  Complete submission text file 0001172661-24-005256.txt   106491
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 241463262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

EIN.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G